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INTRODUCTION 
 
Aging and associated neurodegenerative conditions are a 
serious social problem. The United Nations report that  
 
the population aged > 60 years numbered 962 million in 
2017 comprising 13% of the global population and is 
projected to be 2.1 billion in 2050. In addition, the number 
of the “oldest-old” (>80 years old) is expected nearly to 
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ABSTRACT 
 
Caffeoylquinic acid (CQA) is a natural polyphenol with evidence of antioxidant and neuroprotective effects and
prevention  of  deficits  in  spatial  learning  and  memory.  We  studied  the  cognitive‐enhancing  effect  of  3,4,5‐
tricaffeoylquinic acid (TCQA) and explored its cellular and molecular mechanism in the senescence‐accelerated
mouse prone 8 (SAMP8) model of aging and Alzheimer’s disease as well as in human neural stem cells (hNSCs).
Mice were  fed with 5 mg/kg of TCQA  for 30 days and were  tested  in  the Morris water maze  (MWM). Brain
tissues were  collected  for  immunohistochemical detection of bromodeoxyuridine  (BrdU)  to detect  activated
stem cells and newborn neurons. TCQA‐treated SAMP8 exhibited significantly improved cognitive performance
in MWM compared to water‐treated SAMP8. TCQA‐treated SAMP8 mice also had significantly higher numbers
of BrdU+/glial  fibrillary acidic protein  (GFAP+) and BrdU+/Neuronal nuclei  (NeuN+) cells  in  the dentate gyrus
(DG) neurogenic niche compared with untreated SAMP8.  In hNSCs, TCQA  induced cell cycle arrest at G0/G1,
actin  cytoskeleton  organization,  chromatin  remodeling,  neuronal  differentiation,  and  bone  morphogenetic
protein  signaling.  The  neurogenesis  promoting  effect  of  TCQA  in  the DG  of  SAMP8 mice might  explain  the
cognition‐enhancing influence of TCQA observed in our study, and our hNSCs in aggregate suggest a therapeutic
potential for TCQA in aging‐associated diseases. 
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triple by 2050 [1]. With a rapidly increasing aging 
population, the prevalence of age-related neurodegene-
rative disorders, such as Alzheimer’s disease (AD), is 
expected to rise dramatically in the next few decades. Yet, 
no current therapies effectively treat or cure AD. Amyloid 
beta (Aβ) aggregation forming senile plaques and 
accumulation of tau in neurofibrillary tangles characterize 
AD. These changes lead to neuronal and synaptic loss [2] 
as well as, excitotoxicity, oxidative stress and apoptosis 
[3]. Neuroinflammatory microglial activation is also 
important in the development of AD pathology [4]. All 
these pathophysiological mechanisms of AD are crucial 
for choosing an appropriate animal model. The 
senescence-accelerated mouse prone 8 (SAMP8) mice are 
considered a good model for AD research as they exhibit 
inflammation, vascular impairment, gliosis, in-creased 
oxidative stress, Aβ accumulation, and tau hyper-
phosphorylation, accompanied by deterioration in memory 
and learning [5, 6]. A novel treatment approach of AD and 
other neurodegenerative diseases is to promote neuronal 
replacement in the affected tissue by stimulating neural 
stem cells (NSCs) and neural progenitor cells (NPCs) in 
the neurogenic niches. 
 
Recent studies show that several natural polyphenols could 
promote neurogenesis and are preferable over currently 
used synthetic drugs for the treatment of neuro-
degenerative diseases as they are regarded as safe to use 
with fewer unwanted side effects. Caffeoylquinic acid 
(CQA) is one of the phenylpropanoids found abundantly in 
coffee beans, sweet potatoes, and propolis [7]. We have 
previously reported that CQA has neuroprotective effects 
and activated ATP production due to its strong anti-
oxidative effects in vitro and in vivo [8–10]. Our previous 
findings showed that administration of CQA-rich purple 
sweet potato extract could induce overexpression of 
proteins related to antioxidant, energy metabolism, and 
neuronal plasticity in the brains of SAMP8 mouse [10]. 
Furthermore, among CQA derivatives, 3,4,5-tricaf-
feoylquinic acid (TCQA) has the highest ability to increase 
ATP production in human neuroblastoma SH-SY5Y cells 
[9]. Taken together, we have hypothesized that TCQA 
might promote neurogenesis of NSCs and enhance 
neuronal plasticity due to its antioxidative and neuro-
protective effects. 
 
In the present study, we have performed in vivo 
experiments that postulate TCQA as a new natural 
therapeutic compound for the treatment and prevention 
of age-related diseases. We also have evaluated the 
effects of TCQA on fate determination of human NSCs 
(hNSCs), on oxidative stress, and in cell cycle 
regulation. Furthermore, we have performed a global 
gene expression profiling using DNA microarrays to 
elucidate the neurogenesis-promoting effects of 
TCQA. 
RESULTS 
 
TCQA improved spatial learning and memory of 
SAMP8 mice 
 
To evaluate the effect of TCQA on spatial learning and 
memory in SAMP8 mice, the Morris water maze (MWM) 
test was employed. MWM is a widely used tool to assess 
spatial learning and memory in rodents. In the MWM, the 
animal is placed on a platform concealed under the surface 
of the water in a pool. The swimming time each mouse 
takes to swim to the platform indicates how quickly it can 
recall the location of the platform. To assess the effect of 
TCQA on spatial learning and memory, we measured the 
swimming time of the mice to reach the platform. As 
shown in Figure 1A, the escape latency time of TCQA-
treated SAMP8 mice was significantly decreased compared 
to water-treated SAMP8 mice from 4th to 7th day training. 
On the other hand, there was no difference in the escape 
latency between SAMR1 mice and TCQA-treated SAMP8 
mice. 
 
Figure 1B and 1C show that the time spent in the target 
quadrant and the numbers of time the mouse crossed the 
platform were significantly lower in the water-treated 
SAMP8 group compared to both the TCQA-treated 
SAMP8 group and the water-treated SAMR1 group. 
However, no difference was observed in the occupancy and 
crossing of the target quadrant between the TCQA-treated 
SAMP8 group and the water-treated SAMR1 group. 
 
TCQA stimulates stem cells and increases neuro-
genesis in the dentate gyrus of SAMP8 mice 
 
To study the effects of TCQA on NPC proliferation, we 
performed immunohistochemical detection of BrdU+ cells 
found in the dentate gyrus (DG) and the subventricular 
zone (SVZ) of SAMR1 mice and TCQA-treated and 
control SAMP8 mice. We also performed immuno-
histochemistry for the astrocytic marker GFAP and the 
neuronal marker NeuN. Cells that co-expressed BrdU and 
GFAP (BrdU+/GFAP+ cells) were identified as stem cells 
and cells that expressed BrdU+/NeuN+ were identified as 
newborn neurons. Both the numbers of BrdU+/GFAP+ 
cells and BrdU+/NeuN+ cells were significantly increased 
in TCQA-treated SAMP8 mice compared to untreated 
SAMP8 mice indicating that TCQA induced activation of 
NSC and increased the rate of neurogenesis in the anterior 
DG (Figure 2A–2C). In contrast, there was no significant 
change in the number of BrdU+/GFAP+ cells in the 
posterior DG (Figure 2E). TCQA treatment, however, did 
increase the number of BrdU+/NeuN+ cells in the 
posterior DG. These results suggest that increased 
hippocampal neurogenesis could be related to the 
improvement in learning and memory observed in MWM 
(Figure 1). 
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The SVZ neurogenic niche is not involved in spatial 
memory and can exhibit different molecular regulation 
compared to the DG. Unlike the anterior DG, no 
significant difference was found in the number of 
BrdU+/GFAP+ cells in the SVZ among the three groups 
of mice (Figure 3B). However, the total number of 
BrdU+ cells in the SVZ was significantly increased in 
TCQA-treated SAMP8 mice compared to Water-treated 
SAMR1 mice (Figure 3C). 
 
TCQA increased cell viability of hNSCs 
 
To evaluate the cytotoxicity of TCQA on hNSCs, cell 
viability was examined using the 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay 
(Figure 4). The hNSCs were treated with increasing 
concentrations of TCQA (1, 5, 10, and 20 μM) in 
differentiation medium for 24, 48, 72, and 96 h. TCQA 
increased cell viability in a dose-dependent manner at all 
treatment times compared to corresponding controls 
(Figure 4). Cells treated with 20 μM of TCQA showed 
slightly less viability than the cells treated with 10 μM of 
TCQA at 72 h. 
 
TCQA promoted multilineage differentiation of 
hNSCs 
 
It is known that hNSCs decide their fate within 24 h of 
induction of differentiation and differentiate into  
three kinds of cells; neuron, oligodendrocyte, and 
astrocyte, within three days [11]. We performed immuno-
cytochemistry and western blotting using differentiation 
markers of three kinds of cells: β3-tubulin for neurons, 
MBP for oligodendrocytes and GFAP for astrocytes. 
Before immunocytochemistry and western blotting, we 
evaluated the cytotoxicity of TCQA (1–20 μM) on hNSCs 
by MTT assay. TCQA showed increased cell viability in 
a dose-dependent manner compared to corresponding 
 
 
Figure 1. Effect of 3,4,5‐triCaffeoylquinic acid (TCQA) on spatial  learning and memory as determined by escape  latency of 
senescence‐accelerated resistant mouse 1 (SAMR1) mice, senescence‐accelerated prone mouse 8 (SAMP8) mice and SAMP8 
TCQA‐treated  group  determined  by Morris water maze  (A).  Effect  of  ethanol  extract  of  TCQA  on  the  time  spent  in  the  target 
quadrant (B). Effect of ethanol extract of TCQA on numbers of crossings of platform by SAMR1 untreated and SAMP8 treated or untreated 
mice (C). * P < 0.05, ** P < 0.01 Compared with SAMP8 + water group. 
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control cells at 24 h–96 h (Figure 4). Immuno-
cytochemistry showed that both control and TCQA-
treated cells could differentiate into all lineages (Figure 
5A–5C). However, TCQA substantially increased protein 
levels for all three differentiation markers. Compared to 
control cells, TCQA-treated cells showed significant 
increase in β3-tubulin expression at 24 h and 96 h of 
treatment (Figure 5D), and in MBP expression at 48 h 
and 96 h of treatment (Figure 5E) compared with those of 
control cells. TCQA-treated cells also showed the 
increasing tendency in GFAP expression at 48 h and 96 h 
of treatment (Figure 5F). Glial differentiation takes place 
after neuronal differentiation. Furthermore, imaging by 
confocal laser scanning microscope suggested that TCQA 
 
 
Figure 2. Effect of oral administration of 3,4,5‐triCaffeoylquinic acid (TCQA) on anterior (A–C) and posterior (D–F) DG stem 
cell activation and neurogenesis.  SAMP8 mice were administrated with TCQA  (5 mg/kg)  for 30 days. Photomicrographs show adult 
mouse  brain  in  coronal  sections  containing  the  anterior  (A)  and  posterior  (D)  DG  processed  for  immunohistochemical  detection  of 
proliferating BrdU+ cells (red) and GFAP, a protein expressed by stem cells in the DG (green). Graphs represents the number of BrdU+ cells 
that co‐express GFAP in anterior (B) and posterior (E) DG. Graphs represent the number of BrdU+ cells that co‐express the mature neuronal 
marker NeuN in the anterior (E) and posterior (F) DG. Each bar represents the mean ±SEM * p < 0.05, ** p < 0.01 vs. SAMP8+TCQA group. 
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treatment increased neurite length compared to the 
control condition (Figure 5A). It is known that  
β3-tubulin is expressed in both cell bodies and neurites 
(axons and dendrites) [12]. TCQA increased the 
expression of β3-tubulin in cell bodies at 24 h and 48 h. 
Then, both control and TCQA-treated cells extended 
neurites at 72 h. Finally, at 96 h, TCQA-treated cells 
showed longer neurites similar to axons. These results 
correspond with the protein expression by western 
blotting (Figure 5D). Both control and TCQA-treated 
cells showed very low expression of MBP and GFAP 
compared to the expression of β3-tubulin (Figure 5B and 
5C). 
 
TCQA increased protein expression levels of all 
differentiation markers. There are two possibilities for 
this; first, TCQA promoted differentiation of hNSCs 
and second, TCQA promoted cell proliferation of 
hNSCs. To verify these two theories, we performed 
ViaCount assay to count cell number. hNSCs were 
treated with or without TCQA in differentiation medium 
for 24–96 h. In both untreated control and TCQA-
treated groups, cell numbers were increased at 48h 
compared to 24 h. However, no change was observed in 
the number of cells after 48 h. There was also no 
significant difference in number of cells between control 
and TCQA-treated groups at any treatment time (Figure 
5G). Additionally, cell viability was not changed at any 
treatment time in both control and TCQA-treated groups. 
 
TCQA induced G0/G1cell cycle arrest 
 
Cell cycle regulation is closely related to neurogenesis. It 
is well established that the G0 phase is related to neuronal 
differentiation [13]. Some G0/G1 cell cycle regulators, 
such as tumor suppressor protein p53 (p53), induce 
G0/G1cell cycle arrest and act as transcriptional factors 
modulating proneural gene expression. To investigate 
whether TCQA affects hNSCs cell cycle, we performed a 
cell cycle assay. hNSCs were treated with growth 
medium or differentiation medium with or without 
TCQA for 24 h. In undifferentiated hNSCs, TCQA 
treatment significantly increased the percentage of G0/G1 
phase cells (P = 0.02) while S phase cells showed a 
significant decrease (P = 0.007). Differentiated hNSCs 
included more cells existing in the G0/G1 phase than the 
undifferentiated ones. Moreover, in differentiated hNSCs, 
TCQA increased the ratio of cells existing in G0/G1phase 
compared to control (Figure 6A and 6B). Next, we 
considered the expression of cell cycle regulator p53. 
Phosphorylation of serine 15 in human p53 is an impor-
tant regulator of G0/G1 cell cycle arrest. Phosphorylated 
p53 can activate p21, a cyclin-dependent kinase (CDK) 
inhibitor 1, or CDK-interacting protein 1 and p21 inhibits 
G1/S transition by binding directly to cyclin-CDK com-
plexes. We measured phosphorylation of p53 by western 
blotting. Phosphorylation of p53 was significantly 
increased in TCQA-treated cells at 24, 48 and 96 h and 
decreased at 72 h compared to control cells (Figure 6C). 
 
Figure 3. Effect of oral administration of 3,4,5‐tricaffeoylquinic acid (TCQA) on subventricular zone (SVZ) proliferation. SAMP8 
mice were administrated with TCQA (5 mg/kg) for 30 days (A) Photomicrograph shows adult mouse brain coronal sections containing the SVZ 
processed for  immunohistochemical detection of proliferating BrdU+ cells (red) and GFAP+ (green), an astrocyte marker found  in SVZ NSC.  
(B, C) Graphs represent the number of BrdU+/GFAP+ and BrdU+ cells, respectively in the different treatment groups. 
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TCQA affected intracellular Ca2+ levels, 
mitochondrial function, and intracellular  
reactive oxygen species (ROS) levels during early 
differentiation 
 
Removal of growth factors initiates differentiation by 
inducing several early events. Firstly, Ca2+ is released 
from the endoplasmic reticulum into the cytoplasm in the 
absence of growth factors. Elevated Ca2+ levels in 
mitochondria increase oxidative phosphorylation to 
produce reactive oxygen species (ROS), which in turn 
activate signaling pathways related to neurogenesis. 
Thus, Ca2+ is considered a crucial initial factor of 
differentiation after removal of growth factors. We, 
therefore, investigated whether TCQA affects Ca2+ levels. 
After 1 min of TCQA treatment in undifferentiated cells, 
intracellular Ca2+ levels were significantly increased 
compared with undifferentiated controls (Figure 7A).  
TCQA-treated undifferentiated cells also showed slightly 
higher Ca2+ levels compared with undifferentiated 
control, but not higher than differentiation without 
TCQA, suggesting that it is the differentiation but not the 
TCQA that causes increased Ca2+. After 3 min of 
treatment, the intracellular Ca2+ levels were decreased in 
the TCQA treatment group compared with 1 min of 
TCQA treatment, suggesting that the elevated Ca2+ was 
transported to the mitochondria. After that, the decreased 
Ca2+ levels were gradually restored to baseline (Figure 
7A). 
 
After Ca2+ is transported to mitochondria, mitochondrial 
oxidative phosphorylation is activated.  Mitochondrial 
oxidative phosphorylation uses proton concentration 
gradients between the inner and outer membranes of this 
organelle as driving power. The mitochondrial membrane 
potential (MMP) reflects this proton concentration  
 
 
Figure  4.  The  effect  of  3,4,5‐triCaffeoylquinic  acid  (TCQA)  on  cell  viability  of  human  neural  stem  cells  (hNSCs).  hNSCs  in 
undifferentiated state  (A),  induced differentiation  for 96 h  (B) and  induced differentiation and  treated with TCQA  for 96 h  (C). Time after 
differentiation, hNSCs were treated with TCQA (1, 5, 10, 20 μM) for 24, 48, 72, and 96 h (D). After the treatment, cell viability was measured 
by MTT assay. Data was set as % of control. Data were presented as mean ± SD. ** P < 0.01 Compared with control group. 
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Figure 5. The effect of 3,4,5‐tricaffeoylquinic acid (TCQA) on fate, protein expression levels of differentiation markers, and 
cell proliferation of human neural stem cells (hNSCs). Three differentiation markers (β3‐tubulin: neuron, myelin basic protein (MBP): 
oligodendrocyte, glial fibrillary acidic protein (GFAP): astrocyte) were used. hNSCs were treated with differentiation medium with or without 
10  μM  TCQA.  Expression  levels  of  each  differentiation marker were  observed  using  confocal microscopy.  Immunofluorescence  images 
demonstrating the expression of β3‐tubulin (A), MBP (B), and GFAP (C). hNSCs were treated with differentiation medium with or without 10 
μM TCQA for 24 ‐ 96 h. The expression level of each differentiation marker was determined by western blotting. Immunopositive bands of 
β3‐tubulin  (D), MBP  (E),  and  GFAP  (F) were  quantified  and  expressed  as  a  normalized  value  compared  to  glyceraldehyde‐3‐phosphate 
dehydrogenase  (Gapdh).  The  cell  number  and  cell  viability were measured  by  ViaCount  assay  (G).  *  P  <  0.05,  **  P  <  0.01  significance 
compared with control group. 
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Figure 6. The effect of 3,4,5‐tricaffeoylquinic acid (TCQA) on cell cycle and phosphorylation of tumor protein p53 in human 
neural stem cells (hNSCs). Cell cycle was determined by labeling cellular DNA. hNSCs were treated with growth medium or differentiation 
medium with or without 10 μM TCQA for 24 h. (A) Ratio of each cell cycle phase as a percentage of total cells. (B) The histograms show the 
cells  in G0/G1  (pink peak on  left), S  (green center peak) and G2/M  (blue peak on  right).  (C) hNSCs were  treated with growth medium or 
differentiation medium with or without 10 μM TCQA for 24  ‐ 96 h. Data was set as % of undifferentiated control. Data were presented as 
mean ± SD. * P < 0.05, ** P < 0.01 Compared with undifferentiated control cells. # P < 0.05 significance by student’s t test. 
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gradient. Therefore, we investigated whether TCQA can 
affect mitochondrial oxidative phosphorylation by 
measuring the MMP. hNSCs were treated in a growth 
medium or a differentiation medium without (control) or 
with TCQA for 30–180 min. It was previously reported 
that removal of growth factors could activate mito-
chondrial oxidative phosphorylation in 30–180 min. After 
30 min of treatment, TCQA significantly increased MMP 
compared to both undifferentiated and differentiated 
controls. And, these increased MMP levels were restored 
to baseline after 60 and 180 min of TCQA treatment 
(Figure 7B).  
 
TCQA is known to have high antioxidative activity, so 
there is a possibility that TCQA can reduce cellular 
oxidative stress by inducing differentiation. hNSCs were 
treated in a growth medium or a differentiation medium 
without (control) or with TCQA for 30–180 min. After 
180 min of the treatment, TCQA significantly decreased 
intracellular ROS levels compared with differentiated 
controls (Figure 7C). However, there was no significant 
difference in ROS levels between undifferentiated and 
differentiated controls. 
 
TCQA affects gene expression during differentiation 
 
We observed differences in protein expression of 
differentiation markers at 24h (Figure 8A–8C). We also 
found that hNSCs treated with TCQA could differentiate 
into more committed lineages than control NSCs. 
Numerous stemness-related genes are responsible for 
maintaining the undifferentiated state of NSCs. When 
differentiation is induced by growth factor withdrawal, 
decreased expression of stemness gene and increased 
expression of NSC fate-promoting genes can be observed. 
We, therefore, evaluated the effect of TCQA on global 
gene expression in hNSCs during differentiation at 24h. 
We repeated DNA microarray three times and focused on 
genes whose expression was consistently altered in all 
three experiments. We classified genes into four functional 
groups highly relevant for neurogenesis: actin cytoskeleton 
(Supplementary Table 1), chromatin remodeling, neuronal 
development, and cell cycle-related genes (Table 1). 
Having dual functions, some genes were classified into 
multiple groups. TCQA increased bone morphogenetic 
protein (BMP) signaling pathway-related genes. TCQA 
increased expression of the BMP5 ligand and the BMP 
receptor, type II (BMPR2) (Figure 8A). Furthermore, 
TCQA increased SMAD family member 5 (SMAD5) 
expression, which is activated by BMP signaling pathway 
and acts as a transcription factor during neuronal 
differentiation of hNSCs (Figure 6A) [14]. The expression 
of neuronal differentiation 1 (NEUROD1) is regulated by 
the BMP-SMAD signaling pathway and TCQA also 
increased NEUROD1 expression (Figure 8A). TCQA also 
increased mitogen-activated protein kinase 14 (MAPK14) 
and mitogen-activated protein kinase kinase 6 (MAP2K6), 
which are responsible for coding, and for phosphorylation 
and activation of p38 respectively (Figure 8B). Activated 
p38 directly phosphorylates p53. Furthermore, activated 
p53 acts as a transcriptional factor and regulates zinc finger 
E-box bind 1(ZEB1). ZEB1 is a transcription factor related 
to neuronal differentiation.  We also found that TCQA 
increased activation of the cell division cycle 42 (Cdc42) 
signaling pathway that regulates actin cytoskeleton and 
neurite extension of hNSCs (Figure 8C). 
 
DISCUSSION 
 
The present study sought to evaluate the effects of TCQA 
on spatial learning and memory and adult neurogenesis in 
SAMP8 mice as a model of AD and aging. It 
complemented these experiments with investigations into 
the molecular and cellular neurogenic effects of TCQA. 
The results obtained from the MWM illustrated that the 
TCQA-treated SAMP8 group had significantly increased 
spatial-learning acquisition and retention compared to 
both water-treated SAMP8 and SAMR1 control groups, 
and it, in fact, had similar levels to the SAMR1 control 
group. It is suggestive that TCQA may help to 
ameliorate, reverse or prevent the cognitive dysfunction 
that impairs learning and memory in SAMP8 mice. 
Moreover, the water-treated SAMP8 group remained in 
the platform quadrant less than SAMR1 and 
demonstrated a lower number of entries in the platform 
zone. In contrast, TCQA-treated SAMP8 mice spent 
more time in the platform quadrant and demonstrated 
higher number of entries in the platform zone compared 
to water-treated SAMP8 mice. Thus, three separate 
quantifications showed that the hippocampal dependant 
MWM task was worse in SAMP8 mice than in the 
SAMR1 controls and that TCQA "rescued" the defect. 
 
SAMP8 mice are considered to have several advantages 
compared with other transgenic mice models in 
examining the effects of AD on neurogenesis. Several 
other transgenic mice models only show limited 
pathological hallmarks of AD. SAMP8 mice exhibit not 
only typical features of age-related cognitive impairment 
[15, 16] but also several pathological features of AD, 
including oxidative stress, Aβ alterations and tau 
phosphorylation [17–19]. We were especially interested 
in DG stem cells and neurogenesis since AD frequently 
commences in the hippocampus. Importantly, the number 
of activated DG NSC, as well as newborn neurons, were 
significantly increased in the anterior DG of TCQA-
treated compared to water-treated SAMP8 mice. The 
anterior murine hippocampus has spatial memory 
functions whereas the posterior hippocampus has limbic 
functions [20]. Thus, it was interesting that the TCQA 
had different effects in these two regions; it activated 
both NSC and increased neurogenesis in the anterior DG 
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Figure  7.  The  effect  of  3,4,5‐triCaffeoylquinic  acid  (TCQA)  on  intracellular  Ca2+  levels,  mitochondrial  function,  and 
intracellular  reactive oxygen  species  (ROS)  levels at  very early phase of human neural  stem  cell  (hNSCs) differentiation. 
hNSCs were pre‐treated with Fluo4 AM for 30 min followed by treatment with growth medium or differentiation medium with or without 
TCQA  10  μM  for  1–30  min.  Time  after  differentiation  and  TCQA  treatment,  intracellular  Ca2+  level  was  detected  by  measurement  of 
fluorescence intensity (A). hNSCs were treated with growth medium or differentiation medium with or without 10 μM TCQA for 30–180 min. 
TCQA was treated with rhodamine 123 and detected mitochondrial function by measuring the fluorescence  intensity (B).  Intracellular ROS 
levels were detected by measuring fluorescence intensity of DCF oxidized by ROS. hNSCs were pre‐treated with DCFH‐DA for 1 h followed by 
treatment  with  growth  medium  or  differentiation  medium  with  or  without  10  μM  TCQA  for  15–180  min  (C).  Data  was  set  as  %  of 
undifferentiated control. Data were presented as mean ± SD. * P < 0.01, ** P < 0.01 Compared with undifferentiated control cells. 
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Table 1. Expression changes of cell cycle‐, chromatin remodeling‐, neuronal development‐related genes regulated  
by 3,4,5‐tricaffeoylquinic acid (TCQA). 
Gene title Gene symbol 
Fold 
change Function Category 
Ceramide Kinase Like CERKL 1.51 cell cycle, activation of protein kinase C 
Cell cycle 
Translocated Promoter 
Region, Nuclear Basket 
Protein 
TPR 1.45 negative regulation of mitosis, cell cycle checkpoint 
Structural Maintenance Of 
Chromosomes 4 SMC4 1.42 cell cycle, chromosome organization 
Remodeling And Spacing 
Factor 1 RSF1 1.35 cell cycle, histone binding 
Dual Specificity Tyrosine 
Phosphorylation Regulated 
Kinase 2 
DYRK2 1.32 activation of p53, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth 
Replication Timing 
Regulatory Factor 1 RIF1 1.29 
postsynaptic density, actin projection, Required for 
checkpoint mediated arrest of cell cycle progression in 
response to DNA damage during S-phase (the intra-S-
phase checkpoint) 
Plasminogen-related protein 
B PLGLB 1.28 cell cycle arrest 
Transforming Acidic Coiled-
Coil Containing Protein 3 TACC3 -1.22 
cell cycle, cell proliferation in forebrain, protein transport, 
protein localization 
Anaphase Promoting 
Complex Subunit 7 
ANAPC
7 -1.24 Cell cycle (M phase), protein modification 
DNA Replication And Sister 
Chromatid Cohesion 1 DSCC1 -1.24 cell cycle (M phase), DNA replication 
Polo Like Kinase 4 PLK4 -1.24 cell cycle, regulation of centrosome duplication, protein kinase activity 
Minichromosome 
Maintenance Complex 
Component 4 
MCM4 -1.26 DNA replication, Cell cycle 
HUS1 Checkpoint Clamp 
Component HUS1 -1.30 Cell cycle, DNA repair, G1/S transition 
SET domain containing 
(lysine methyltransferase) 8 SETD8 -1.31 
Cell cycle (M phase), chromatin modification, negative 
regulation of gene and protein expression, methyl 
transferase 
alpha-thalassemia ATRX 1.71 DNA repair, DNA methylation, zinc ion binding, forebrain development 
Chromatin 
remodeling 
Bromodomain Adjacent To 
Zinc Finger Domain 1A BAZ1A 1.44 transcription, zinc ion binding, chromatin remodeling 
Lysine-specific demethylase 
5A KDM5A 1.37 
chromatin organization, oxidation reduction, zinc ion 
binding 
Nuclear Receptor 
Corepressor 1 NCOR1 1.36 
chromatin organization, negative regulation of 
transcription from RNA polymerase II promoter, negative 
regulation of JNK cascade, promotes histone deacetylation 
Bromodomain Adjacent To 
Zinc Finger Domain 1B BAZ1B 1.31 
chromatin organization, chromatin remodeling,  chromatin 
regulation / acetylation 
Potassium Voltage-Gated 
Channel Subfamily Q 
Member 1 
KCNQ1 1.30 chromatin regulation 
SKI proto-oncogene SKI 1.30 
negative regulation of transcription from RNA polymerase 
II promoter, negative regulation of activin receptor 
signaling pathway, TGF-beta signaling 
GLIS Family Zinc Finger 3 GLIS3 1.28 chromatin organization, zinc ion binding 
AT-rich interactive domain-
containing protein 2 ARID2 1.28 
Required for the stability of the SWI/SNF chromatin 
remodeling complex 
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Gene title Gene symbol 
Fold 
change Function Category 
runt-related transcription 
factor 1; translocated to, 1 
(cyclin D-related) 
RUNX1
T1 1.28 
chromatin organization, zinc ion binding, binding to 
histone deacetylases and transcription factors 
G Protein Subunit Beta 4 GNB4 1.28 negative regulation of transcription from RNA polymerase II promoter 
Chromodomain Helicase 
DNA Binding  
Protein 4 
CHD4 1.25 chromatin organization, SNF2-related, remodeling of chromatin by deacetylating histones 
Myb Like, SWIRM And 
MPN Domains 1 MYSM1 1.24 chromatin organization 
Spen Family Transcriptional 
Repressor SPEN 1.23 
regulation of transcription from RNA polymerase II 
promoter, Notch signaling, negative regulation of 
transcription 
Zinc Finger E-Box Binding 
Homeobox 1 ZEB1 1.43 
negative regulation of transcription from RNA polymerase 
II promoter, zinc ion binding, Positively regulates 
neuronal differentiation 
Neuronal 
deveropment 
Bone Morphogenetic Protein 
5 BMP5 1.33 Hedgehog signaling pathway, TGF-beta signaling pathway 
Bone morphogenetic protein 
receptor type 2 BMPR2 1.28 BMP signaling 
RAR Related Orphan 
Receptor A RORA 1.27 neuron differentiation, cell differentiation in hindbrain, 
SMAD Family Member 5 SMAD5 1.22 BMP signaling 
Neurobeachin NBEA 1.22 neuronal post-Golgi membrane traffic 
Leucine Rich Repeat 
Transmembrane Neuronal 1 
LRRTM
1 1.22 
neuron projection, axon, growth cone, exhibits strong 
synaptogenic activity 
Neuronal Differentiation 1 NEUROD1 1.20 neuron differentiation, cell cycle arrest 
 
but only increased neurogenesis in the posterior DG. 
Interestingly, TCQA stimulated proliferation in the  
SVZ but not NSC activation and future work will be 
needed to elucidate how these niches are differentially 
regulated by TCQA. TCQA induced hippocampal 
neurogenesis in both mouse adult NSC in vivo and 
human embryonic derived NSC cultures. Unfortunately, 
to the best of our knowledge, there are no reports about 
the pharmacokinetics of TCQA. However, Dan and 
colleagues reported that di-CQAs derivatives were 
absorbed after oral administration and the degradation 
products, mono-CQAs and caffeic acid (CA), were 
mostly found in tissues such as lung, kidney, brain, 
intestine, and small intestine, but not in plasma [21]. 
Therefore, we considered that after administration, 
TCQA was also degraded to mono-CQAs and caffeic 
acid, and mainly mono-CQAs and caffeic acid induced 
neurogenesis. On the basis of these findings, we infer 
that TCQA-treatment improves spatial learning and 
memory through increased neurogenesis of hippo-
campal DG in SAMP8 mice. 
 
In the previous study, we showed that 3,5-diCQA was 
found to improve spatial learning and memory in 
SAMP8 using MWM test [8]. Moreover, CQA 
derivatives have been reported to exert neuroprotective  
 
effects and promotion of energy metabolism through t 
overexpression of glycolysis-related [8], TCA cycle-
related [10], and intracellular ATP production-related 
genes [8, 9]. Furthermore, in the previous result of 
metabolomics analysis, TCQA and 3,5-diCQA 
exhibited promotion of central metabolic pathways 
such as glycolysis and the TCA cycle [22]. 
Interestingly, TCQA showed the highest activity of 
promotion of ATP production and energy metabolism 
among other CQAs derivatives [9, 22]. Neurons have 
high energetic demands for the maintenance and 
restoration of ion gradients dissipated by the repeated 
generation of postsynaptic potentials and action 
potentials, and the neurotransmitter cycle in the brain 
[23]. The previous report showed that neural stem and 
progenitor cells isolated from aged mouse forebrains 
display an aberrant metabolic phenotype characterized 
by decreased mitochondrial mass, lower oxygen con-
sumption rates, and increased resistance to mito-
chondrial inhibitors, suggesting that mitochondrial 
function during aging contributes to impaired 
neurogenesis [23]. Therefore, we assume that TCQA, 
having the highest activity of promotion of energy 
metabolism, would also have the highest potential of 
the induction of adult neurogenesis compared with 
other CQA derivatives. 
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Figure 8. The effect of 3,4,5‐tricaffeoylquinic acid (TCQA) on gene expressions related to bone morphogenetic protein (BMP) 
signaling pathway. Human neural stem cells  (hNSCs) were  treated with differentiation medium with or without 10 μM TCQA  for 24 h. 
Genes expressing BMP ligand BMP5, BMP receptor 2 and SMAD5 downstream BMP signaling pathway as well as the neuronal differentiation 
transcription factor NEUROD1 were increased by TCQA (A). Genes related to p38–p53 signaling pathway regulating G0/G1 cell cycle arrest of 
hNSCs activated by the BMP signaling pathway were increased by TCQA (B). Genes related to the Cdc42 signaling pathway regulating neurite 
extension and activated by the BMP signaling pathway were increased by TCQA (C). Data was set as % of undifferentiated control. Data were 
presented as mean ± SD. ** P < 0.01 Compared with undifferentiated control. 
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The central nervous system (CNS) has high energy 
demands for nerve transduction, survival, proliferation, 
and differentiation. In this study, TCQA increased 
mitochondrial function and increased hNSC viability. 
NSCs, which are in the proliferative state, rely on 
glycolysis for their energy production [24]. The 
differentiation of NSCs gradually relies on oxidative 
phosphorylation, which is accompanied by the electron 
transport chain in mitochondria [25]. Therefore, 
enhanced mitochondrial activity is suggestive of NSC 
differentiation. As described above, NSCs can 
differentiate into three lineages: neurons, oligodendro-
cytes, and astrocytes. In this study, we found that TCQA-
treated hNSCs expressed differentiation markers of all 
three lineages (β3-tubulin, MBP, and GFAP). We 
performed western blotting to measure differentiation 
markers and immunocytochemistry to evaluate neurite 
outgrowth, which is the main characteristic of 
differentiating cells [26]. Our results showed that TCQA-
treated hNSCs eventually increased differentiation 
markers compared with control cells, especially β3-
tubulin expressed primarily in young neurons. Our results 
also showed that TCQA-treated hNSCs transiently 
increased GFAP and MBP expression. GFAP is widely 
used as an astrocyte marker [27] and is also expressed in 
NPCs. In contrast, MBP is widely accepted as a marker 
of adult oligodendrocytes [28]. Altogether, our results 
suggested that TCQA promoted differentiation of hNSCs 
at least toward the neuronal lineage and suggests the 
possibility of using TCQA to promote neurogenesis. 
However, the mechanism resulting in this effect of 
TCQA is still unclear. Therefore, we also evaluated 
whether TCQA affects early events in differentiation and 
gene expression. 
 
Because cell cycle regulation is involved in a large array 
of intracellular differentiation events, we also studied the 
effects of TCQA on cell cycle regulation. TCQA-treated 
cells increased the ratio of cells in the G0/G1 phase in 
both undifferentiated and differentiated cells. It is widely 
known that G0/G1 cell cycle arrest is related to 
differentiation, as G0/G1 cell cycle progression factors 
negatively regulate basic helix-loop-helix, a protein 
structural motif that characterizes a family of trans-
cription factors, responsible for neurogenesis [29]. In 
addition, the phosphorylation of p53, an important 
regulatory factor of G0/G1 arrest, was increased by 
TCQA-treatment. Our microarray results showed that 
several genes related to cell cycle were affected by 
TCQA-treatment. DYRK2 acts as an activator of p53 and 
negative regulator of G1/S transition [30]. RIF1 acts in 
the checkpoint of G1/S and increases G0/G1 arrest [31]. 
TCQA-treated cells increased both DYRK and RIF1 up to 
1.32 and 1.29 respectively, suggesting the suppression of 
G1/S transition and the increase of G0/G1 arrest. SETD8 
and MCM4 begin to be expressed at S phase and reach 
expression peaks at G2/M phase, thus, the down-
regulation of SETD8 and MCM4 to -1.31 and -1.26 
respectively, suggests the ratio of cells in S-G2/M phase 
was decreased. Similarly, HUS1 acts during S phase as a 
DNA damage checkpoint [32] and PLK4 promotes DNA 
replication through duplicating centrosomes [13]. DSCC1 
is a component of the alternative replication factor 
complex (RFC) and loads PCNA on DNA [33, 34]. The 
decrease in expression of these genes (HUS1: -1.30, 
PLK4: -1.24, DSCC1: -1.24, respectively) related to 
DNA replication is in concert with the finding the 
proportion of cells in S phase being decreased by TCQA. 
ANAPC7 (-1.24) is a component of anaphase-promoting 
complex/cyclosome and controls G1 phase progression 
[35]. TACC3 (-1.22) is suppressed by the activated p38-
p53-p21 signaling pathway and induces G0/G1 arrest 
[36]. In this study, p53 was activated and gene expression 
of MAP2K6 (1.23), which phosphorylates p38 protein, 
and MAPK14 (1.22), which activates the JNK signaling 
pathway, was increased by TCQA treatment. From these 
results, it is assumed that TCQA increased G0/G1 arrest 
by negatively regulating G1/S transition via changing 
expressions of various genes and moving hNSCs toward 
more lineage-committed cells. It is important to note that 
modulating cell cycle phase lengths can regulate rates of 
neurogenesis in vivo in the cerebral cortex and the dentate 
gyrus stem cell niche [37, 38]. Thus, it will be fascinating 
to dissect with functional studies which of the genes 
above are necessary for TCQA’s effects on neurogenesis. 
Actually, our microarray result showed that the fold 
change of gene expression was usually below 1.5-fold. 
Therefore, using stringent criteria for differentially 
expressed genes may lead to overlooking some important 
biological functions. Thus, to understand the integrative 
response of cells to TCQA treatment, we chose to 
evaluate genes that did not vary widely in expression but 
had important biological significance [39]. 
 
A series of events occurred in response to the removal 
of growth factors from NSCs to induce differentiation. 
Intracellular Ca2+ levels were increased immediately 
after the removal of growth factors. Then after 3 min of 
removal of the growth factors, the Ca2+ levels were 
decreased in both control cells and TCQA-treated cells 
(Figure 7A). This result suggested that Ca2+ was 
released from the endoplasmic reticulum (ER), was 
transported to the mitochondrial matrix through Ca2+ 
transporters located at the ER-mitochondria contact site 
to the cytosol [40], and consequently was transferred to 
mitochondria. In addition, TCQA-treated cells increased 
MMP at 30 min compared to differentiated control 
cells. Activated mitochondria produce ROS and energy 
by mitochondrial oxidative phosphorylation. ROS can 
induce signal transduction related to neurogenesis under 
normal conditions. However, overproduction of ROS 
leads to mitochondrial DNA damage and eventually 
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negatively affects neurogenesis [41]. The production of 
ROS was significantly decreased by the induction of 
differentiation in TCQA-treated cells compared to 
differentiated cells. However, no significant difference 
was observed in production between TCQA-treated and 
undifferentiated cells. 
 
Importantly, TCQA-treated cells exhibited increased 
expression of several genes related to neuronal 
development. Neurobeachin is important for the for-
mation and composition of central synapses and is also 
essential for neuromuscular synaptic transmission [42, 
43]. ZEB1 acts as a neuronal transcription factor and 
positively regulates neuronal differentiation [44]. Our 
results showed that TCQA also increased BMP 
signaling pathway-related genes. As well as the actin 
cytoskeleton, the BMP signaling pathway has strong 
effects on neural fate commitment. BMP signaling 
initially promotes neurogenesis by pushing progenitors 
towards the neuronal fate and suppressing the 
oligodendroglial fate [11]. In addition, SMAD5 is a 
transcription factor, which is a pivotal intracellular 
effector of the BMP signaling pathway. SMAD5 is 
activated by BMP-binding the BMP receptor. Further-
more, BMP signaling induces expression of neuron-
specific β3-tubulin. Besides, TCQA-treated cells also 
exhibited increased expression of NEUROD1, which 
acts as a transcriptional factor for neuronal differen-
tiation genes under activated BMP-SMAD signaling. 
These results suggested that TCQA might promote 
neuronal differentiation through the BMP signaling 
pathway. 
 
Axonal transport is another important cellular process 
of neurons that transports mitochondria, lipids, synaptic 
vesicles, proteins, and other cell components between 
the cell body and axons. Axonal transport occurs 
throughout life in neurons for their survival. Kinesin 
and dynein are important motor proteins, which move 
cargoes anterogradely (from the cell body to axon tip) 
and retrogradely (from axon to cell body), respectively 
[45]. Kinectin 1 (KTN1), a kinesin receptor, and kinesin 
family member protein 21A (KIF21A), one of the motor 
proteins of kinesin, were increased by TCQA treatment 
(Supplementary Table 1). Furthermore, the expression 
of dynein cytoplasmic 1 light intermediate chain 2 
(DYNC1LI2) and dynein cytoplasmic 1 heavy chain 1 
(DYNC1H1) were also increased in TCQA-treated cells 
compared to non-treated cells (Supplementary Table 1). 
The increased expression of these genes suggests that 
the elongated neurites might have neuronal functions. 
Current evidence suggest that deficits in axonal 
transport contribute to the pathogenesis of several 
neurodegenerative disorders [46]. 
CONCLUSION 
 
The development of new strategies to promote 
neurogenesis in aging-related diseases is a major thera-
peutic challenge. Our results suggest that TCQA-
treatment improves spatial learning and memory through 
the increase of neurogenesis of hippocampal DG. 
Importantly we showed that TCQA also has pro-neuro-
genic effects in human cells, that may occur via 
activation of the BMP signaling pathway. We, therefore, 
postulate that TCQA could be a new agent capable of 
increasing NPC proliferation in the DG and improve 
learning and spatial memory. Therefore, it will be 
important to determine how functionally mature and 
long-lived the new neurons are and if they are directly 
responsible for various aspects of memory. It may also be 
possible to modify TCQA to create an optimal new 
therapeutic drug for the treatment of aging-associated 
neurodegenerative diseases. 
 
MATERIALS AND METHODS 
 
TCQA preparation 
 
We used TCQA for our study as it promotes the highest 
neuronal ATP production compared with other CQA 
derivatives [9]. As the extraction and purifica-
tion/isolation of a large amount of TCQA from plant 
materials / natural biological sources is difficult, we used 
synthesized TCQA. Dr. Kozo Sato from Synthetic 
Organic Chemistry Laboratories, the FUJIFILM 
Corporation (Kanagawa, Japan) provided us with the 
synthesized TCQA with 97% purity. TCQA was 
dissolved in 70% EtOH (TCA stock), and then, for in 
vitro assays, TCA stock was dissolved in the medium. 
For in vivo assays, TCA stock was dissolved in drinking 
water. 
 
Animal subjects, TCQA administration and Bromo-
deoxyuridine (BrdU) labeling 
 
Four-month-old adult male SAMP8 and SAMR1 
(purchased from the Japan SLC company, Japan) mice 
were used for the experiment. All mice were allowed to 
acclimate to the laboratory conditions for seven days under 
controlled conditions of temperature (21–23ºC) and light 
(light: dark 12:12) with free access to food and water. 
SAMP8 mice were randomly divided into two groups, 
SAMP8 control group (n = 6) and TCQA-supplemented 
group (n = 7). SAMR1 mice (n = 10) were used as normal 
aging controls. TCQA (5 mg/kg) was mixed with drinking 
water and then was directly administered by oral gavage 
with a feeding tube and a syringe every day for 30 days. 
BrdU (1mg/ml) was diluted in drinking water and was 
provided to the animals for nine consecutive days starting 
from the 14th day of TCQA treatment. The schedule of 
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BrdU administration followed by washout and sacrifice 
was chosen, as it is capable of detecting differences in 
stem cell activation as well as neurogenesis. All animal 
procedures were approved by the Animal Study 
Committee of University of Tsukuba (No.16–042) and 
were handled according to the guidelines for the Care and 
Use of Animals approved by the Council of the 
Physiological Society of Japan. 
 
Morris Water Maze (MWM) 
 
MWM was carried out using a circular pool (120 cm in 
diameter and 45 cm in height) with a featureless inner 
surface. The pool was filled to a depth of 30 cm with 
water (23 ± 2°C) and was divided into four quadrants. A 
platform (10 cm in diameter) was placed in the northeast 
quadrant and was submerged 1 cm below the water 
surface so that it was invisible at water level. The mice 
were then given four trial sessions each day for one week 
on a platform fixed in the same location for the whole 
duration of the experiment. Each mouse was placed on 
the platform for 15 s every day for 7 days. 
 
After 7 days of trials, the hidden platform was removed 
from the pool and the mice were then placed in the opposite 
location of the platform and were allowed to swim for 60 s. 
The number of crossings over the previous position of the 
platform and the time spent in the target quadrant in which 
the platform was hidden during the acquisition trials were 
recorded as measures for spatial memory. 
 
Tissue processing and immunostaining 
 
At the end of MWM, animals were sacrificed and brains 
were removed. Ten brains of SAMR1 mice, six brains of 
SAMP8 control mice and seven brains of TCQA 
supplemented SAMP8 mice were harvested. The brains 
were fixed in 4% paraformaldehyde (PFA) for 24 h and 
then cryoprotected in 30% sucrose (w/v) in phosphate 
buffered saline (PBS) for 48 h, both at 4 ºC. Serial 30 µm 
coronal brain sections were obtained using a microtome on 
dry ice. Sections were stored at -20ºC in cryoprotectant 
solution (ethylene glycol, glycerol, 0.1 M phosphate 
buffer, pH 7.4, 1:1:1:2 by volume). Sections were washed 
in 0.1 M PBS 3 × 10 min and then blocked with 50 mM 
glycine in PBS to reduce autofluorescence of PFA-fixed 
tissue. For immunohistological detection of BrdU, sections 
were incubated in HCL (2N) at 37ºC for 1 h before 
blocking. Sections were washed in PBS, before blocking 
for 1 h in PBS containing 0.1% Triton X-100 and 10% 
Donkey Serum (DS, Sigma). Primary antibodies used were 
anti-BrdU (1:400, sheep, Abcam Ab1893), anti-GFAP 
(1:500, rat, Invitrogen, AF568), anti-NeuN (1:400, mouse, 
Millipore MAB377). The secondary antibodies were 
conjugated to Alexa-488, -568 or -647 (Invitrogen Paisley, 
Renfrewshire, UK; 1:500). 
Culture of hNSCs 
 
The hNSCs derived from H9 hNSCs were purchased 
from Gibco, Japan. The hNSCs were cultured in 60 mm 
Petri dishes (BD Falcon) or in 6-well plates (BD Falcon) 
with a growth medium Knock OutTM:1:1 (v/v) mixture of 
Dulbecco’s minimum essential medium (Sigma, U.S.A.) 
and Ham’s F-12 nutrient mixture (Sigma, U.S.A.) 
supplemented with 2% StemPro neural supplement, 20 
ng/mL of fibroblast growth factor (FGF) basic 
recombinant human, 20 ng/mL epidermal growth factor 
(EGF) recombinant human and 2 mM GlutaMAX-I 
supplement. For adhesion, 60-mm Petri dish or 6-well 
plate coated with CELLStart were used. The hNSCs were 
cultured at 37ºC in a 95% air / 5% CO2 humidified 
incubator. The medium was changed every two days to 
keep cells undifferentiated. 
 
Determination of cell viability 
 
Cell viability was measured using the MTT assay. hNSCs 
were treated with 5–30 μM of TCQA for 72 h. After 
TCQA treatment, 5 mg/ml of MTT was added and the 
cells were incubated for further 12 h. The MTT formazan 
was dissolved in 100 μl of 10 % SDS (w/v). Absorbance 
(570 nm) was measured using a microtiter plate reader 
(Dainippon Sumitomo Pharma Co., Ltd., Japan). 
 
Differentiation assay and immunocytochemistry 
 
To induce differentiation, hNSCs were seeded into 
CELLStart coated culture vessels at the density of 2.5 x 
104 cells/cm2. After 48 h, growth medium was replaced 
by differentiation medium without growth factors: 
KnockOut DMEM/F12 supplemented with 2% StemPro 
neural supplement and 2 mM GlutaMAX-I supplement. 
The medium was changed every 2 to 3 days. For immu-
nocytochemistry, cells were seeded in the Nunc Lab-Tek 
Chamber Slide System (Thermo Scientific, Japan) at the 
same density and were incubated at 37ºC for 48 h. After 
incubation, cells were treated with differentiation 
medium with or without TCQA at 37ºC for 24–96 h. 
After treatment, cells were washed with PBS and were 
fixed with 4% (w/v) PFA diluted in PBS for 30 minutes 
at room temperature. The fixed cells were washed with 
PBS 3 times for 5 minutes. After washing, cells were 
blocked overnight at 4ºC with saturation solution of 5% 
Fetal Goat Serum and 0.1% TritonX-100 (Sigma, Japan) 
in PBS. Blocking buffer was removed after incubation 
and primary antibodies (Novex Goat anti-Rabbit IgG 
(H+L), Sigma, Japan) were added in a specific antibody 
dilution buffer (1% Bovine Serum Albumin and 0.3% 
TritonX-100 in PBS). After the incubation with the 
primary antibody overnight at 4ºC, cells were washed 
with PBS and incubated with the secondary antibody 
(Alexa Flour 488 conjugate goat anti-rabbit IgG (H+L) 
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(1:1000), Thermo SCIENTIFIC, Japan) for 1–2 h at room 
temperature avoiding light exposure. After incubation, 
cells were washed with PBS and nuclei were 
counterstained with DAPI using drops of ProLong Gold 
Antifade Mountant (Thermo Scientific, Japan). 
Fluorescence was detected with Leica DMI 4000B 
(Leica, Germany). 
 
Protein extraction 
 
The hNSCs were seeded in 60 mm Petri dish (BD 
Falcon) at the density of 2.5×104 cells/cm2 and were 
incubated at 37ºC for 48 h. After the incubation, cells 
were treated with differentiation medium with or without 
10 μM TCQA for 24–96 h at 37ºC. After the treatment, 
cells were washed with cold PBS twice and then 100 μl 
of RIPA buffer (Sigma, Japan) including 1% protease 
inhibitor (Sigma, Japan) was added. Cells were incubated 
for 5 min on ice and cell lysate was collected in Cryo-
tubes and was frozen in liquid nitrogen for 15 min. The 
frozen solution was melted on the ice and centrifuged 
(4ºC, 10,000g, 15 min) in 1.5 ml Protein LoBind Tube 
(Eppendorf, Japan). The supernatants were transferred 
into new tubes and protein concentrations were 
quantified with 2-D Quant kit (GE Healthcare, Japan). 
Protein samples were stored at -80ºC until use. 
 
Western blotting 
 
Protein samples (20 µg) were separated using 10% SDS-
PAGE and were transferred to a polyvinylidene 
difluoride membrane (PVDF, Merck Millipore, USA). 
Western blot was performed as previously described 
(Matsukawa et al., 2017). Primary antibodies used were 
anti-β-III-Tubulin (CST, Japan); anti-myelin basic 
protein (MBP) (Sigma, Japan); anti-glial fibrillary acidic 
protein (GFAP) (Sigma, Japan); anti-glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (1:200, Santa Cruz, 
Japan); rabbit anti-Phospho-p53 (S15, CST, Japan) and 
rabbit anti-p53 (1:1000, CST, Japan). Secondary 
antibodies were IRDye 800CW donkey anti-rabbit IgG 
(1:1000) or IRDye 680LT goat anti-mouse (1:20000) 
from LI-COR, Inc., Lincoln, NE, USA. The signal was 
detected using the Odyssey FC Imaging System (LI-
COR, Inc, NE, USA). 
 
Cell cycle assay 
 
Guava Cell Cycle Reagent (Millipore, Japan) was used to 
evaluate the effects of TCQA on cell cycle regulation in 
undifferentiated and differentiated cells. The hNSCs were 
cultured in 60 mm Petri dishes at a density of 2.5 × 104 
cells/cm2 and were incubated at 37ºC for 48 h. Cells were 
treated with or without TCQA (10 µM) in growth or 
differentiation medium at 37ºC for 24 h. After 
incubation, cells were washed and treated with StemPro 
accutase to detach from the dish and were centrifuged 
twice at 200 g for 4 min. One ml of cold 70% ethanol 
was next added and cells vortexed. Cells were fixed at 4 
ºC for 1–12 h. Then the cells were centrifuged twice at 
450 g for 5 min. After the last centrifugation, Guava Cell 
Cycle Reagent (Guava Technologies, Japan) was added 
to cells and was incubated for 30 min at room 
temperature in the darkness. After incubation, cell cycle 
was determined using Guava easyCyte (Millipore, 
Japan). 
 
Measurement of intracellular Ca2+ levels in hNSCs 
 
After inducing differentiation of hNSCs into neurons by 
removal of growth factors, intracellular Ca2+ level 
immediately changes to activate certain signaling 
pathways. Therefore, intracellular Ca2+ levels were 
determined to evaluate the effect of TCQA at a very early 
phase of differentiation using Calcium KitⅡ -Fluo 4 
(Dojindo, Japan). 
 
hNSCs were seeded at 2.5 × 104 cells/cm2 in black clear 
bottom 96-well plates (Greiner). After 48 h of incubation, 
cells were pre-treated with 100 μl of Loading buffer (5% 
Pluronic F-127,250 mmol/l Probenecid and 1 μg/μl Fluo 
4 AM in Hanks’ HEPES Buffer) for 30 min. After that, 
the supernatant was removed and cells were washed with 
PBS and treated with differentiation medium without 
(control) or with 10 μM of TCQA. The cells were 
incubated at 37ºC for 1–180 min in the dark. After the 
treatment, fluorescence intensity (495 nm/535 nm) was 
detected using a microplate reader and was calculated as 
a percentage of control. 
 
Rhodamine 123 uptake measurement 
 
Rhodamine 123 is a fluorescent probe that stains 
mitochondria directly. In this study, rhodamine 123 was 
used to evaluate mitochondrial membrane potential 
(ΔMMP). Once hNSCs were induced to differentiate, 
intracellular Ca2+ was released from the endoplasmic 
reticulum and subsequently, Ca2+ was transported to 
mitochondria. Because mitochondrial Ca2+ levels 
modulate ATP and ROS production, rhodamine 123 was 
used for evaluating mitochondrial activity. Rhodamine 
123 (Wako, Japan) was dissolved in DMSO at 100 
mg/ml. hNSCs were seeded at 2.5 × 104 cells/cm2 in 96-
well plates (BD Falcon) and incubated at 37ºC for 48 h. 
After the incubation, hNSCs were treated in a growth 
medium or a differentiation medium without (control) or 
with 10 μM of TCQA and were incubated at 37ºC for 
30–180 min. After the treatment, hNSCs were washed 
with PBS and were treated with rhodamine 123 (10 
μg/ml), dissolved in 10 mM HEPES-HBSS buffer (pH 
7.4), and incubated at 37ºC for 20 min. After the 
incubation, hNSCs were washed with cold-PBS, lysed 
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with 1% Triton-X solution (200 μl/well) and incubated at 
room temperature for 30 min avoiding light exposure. 
After the incubation, the cell lysate was transferred into a 
black clear bottom 96-well plate and the fluorescence 
intensity (507 nm/529 nm) was measured. Uptake levels 
of rhodamine 123 were calculated as a percentage of 
control. 
 
Measurement of intracellular ROS level 
 
Removal of growth factors to induce differentiation 
of hNSCs causes an elevation of the intracellular Ca2+ 
level, which in turn activates ROS. Under normal 
physiological conditions, ROS activate certain signal-
ing pathways, however, excess ROS can induce oxi-
dative stress that harms cells. Therefore, the effects 
of TCQA on intracellular ROS level was determined 
using the OxiSelect Intracellular ROS assay kit 
(Cosmo Bio, Japan) following the manufacturer’s 
procedures. 
 
hNSCs (2.5 × 104 cells/cm2) were seeded in black clear 
bottom 96-well plates and were incubated in medium 
with TCQA for 1 h. The cells were then incubated with 
10 μM DCFH-DA at 37°C for 1 h and washed with PBS. 
The fluorescence intensity of dichlorofluoresein (DCF) 
was measured using a microtiter plate (Dainippon 
Sumitomo Pharma Co, Ltd., Japan) reader at excitation 
wavelength of 485 nm and emission wavelength of 528 
nm. Intracellular ROS was monitored using the fluo-
rescent probe DCFH-DA. Intracellular H2O2 or low-
molecular-weight peroxides oxidize DCFH-DA to the 
highly fluorescent compound DCF. 
 
RNA isolation from hNSCs 
 
The hNSCs were seeded in 60-mm Petri dishes at the 
density of 2.5×104 cells/cm2 and were incubated at 
37ºC for 48 h. After that, cells were treated with 
differentiation medium with or without 10 μM of 
TCQA and were incubated at 37ºC for 6–24 h. After 
the treatment, cells were washed with ice-cold PBS. 
The total RNA was extracted from the cells using 
ISOGEN kit (Nippon Gene Co. Ltd., Toyama, Japan) 
following manufacturer’s instructions, as reported 
previously (Han et al., 2010). Total RNA was quan-
tified and assessed for quality with a NanoDrop 2000 
spectrophotometer (Thermo Scientific, Wilmington, DE, 
USA). 
 
DNA microarray analysis 
 
Double-stranded cDNA was synthesized from 100 ng of 
total RNA with the GeneAtlas 3’ IVT Express Kit 
(Affymetrix Inc., Santa Clara, CA, USA). Biotin-labeled 
amplified RNA (aRNA) was synthesized by in vitro 
transcription using the GeneChip 3’ IVT Express Kit 
(Affymetrix Inc., Santa Clara, CA, USA). A total of 9.4 
mg of purified aRNA was fragmented using the 
GeneAtlas 3’ IVT Express Kit and was hybridized for 16 
h at 45°C using GeneChip MG-430 PM microarray 
(Affymetrix Inc., Santa Clara, CA, USA). The chip was 
washed and stained in the Gene Atlas Fluidics Station 
400 (Affymetrix Inc., Santa Clara, CA, USA) and then 
the resulting image was scanned using the GeneAtlas 
Imaging Station (Affymetrix Inc., Santa Clara, CA, 
USA). Data analysis was performed using the Partek 
Express software (Partek Inc., St. Louis, MO, USA) 
provided by Affymetrix as part of their GeneAtlas 
system. Compared with the non-treated cells, fold change 
in expression in the TCQA-treated group was calculated 
and converted to log 2 data. 
 
Statistical analysis 
 
All analyses were performed on blind-coded slides as 
previously described [47]. Statistical analysis was 
performed using GraphPad Prism 6 (GraphPad 
Software, Inc., San Diego, CA). A Student’s t-test was 
used when two groups were compared. Results are 
expressed as mean ± standard error of the mean (SEM). 
Statistical analysis of the results obtained in the MWM 
was carried out using two-way ANOVA with Ryan-
Einot-Gabriel-Welsch multiple range test. One-way 
ANOVA followed by Ryan-Einot-Gabriel-Welsch 
multiple range test was also done. A P value of < 0.05 
was considered statistically significant. 
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SUPPLEMENTARY MATERIAL 
 
 
 
Supplementary Table 1. Expression changes of Actin cytoskeleton‐related genes regulated by 3,4,5‐triCaffeoylquinic 
acid (TCQA). 
Gene title Gene symbol 
Fold 
change Function Category 
EH Domain Binding 
Protein 1 EHBP1 1.63 actin binding, alternative splicing 
Actin 
cytoskeleton 
Protein Kinase N2 PKN2 1.40 
inhibits Akt pro-survival-induced kinase activity, cell cycle 
progression, actin cytoskeleton assembly, cell migration, 
cell adhesion 
Radixin RDX 1.40 regulation of actin polymerization and de- polymeratization, regulation of actin length 
Transmembrane Protein 
106B 
TMEM1
06B 1.39 dendrite morphogenesis 
Kinectin 1 KTN1 1.37 microtubule-based process, microtubule-based movement, actin cytoskelton 
IQ Motif Containing 
GTPase Activating 
Protein 1 
IQGAP1 1.36 actin cytoskeleton, calcium ion binding, binding activated cdc42, promote neurite outgrowth 
Actin, Alpha 2, Smooth 
Muscle, Aorta ACTA2 1.35 actin cytoskeleton 
CDC42 Binding Protein 
Kinase Alpha 
CDC42B
PA 1.30 
cytoskeleton organization, protein kinase activity, zinc ion 
binding 
Kelch Like Family 
Member 17 KLHL17 1.29 
regulation of actin cytoskeleton organization, activation of 
protein kinase activity, this protein may play a key role in 
the regulation of actin-based neuronal function. 
Coiled-Coil Domain 
Containing 88A 
CCDC88
A 1.28 
plays a role in cytoskeleton remodeling and cell migration, 
correct neuron positioning, dendritic development and 
synapse formation 
Junction Mediating And 
Regulatory Protein, P53 
Cofactor 
JMY 1.27 
stem cell differentiation, acts both as a nuclear p53/TP53-
cofactor and a cytoplasmic regulator of actin dynamics, may 
promote the rapid formation of a branched actin network 
LanC Like 2 LANCL2 1.25 cortical actin cytoskeleton 
transforming acidic 
coiled-coil-containing 
protein 1 
TACC1 1.25 microtubule cytoskeleton, cell cycle 
Protein Phosphatase 1 
Regulatory Subunit 12A 
PPP1R12
A 1.25 
phosphoprotein phosphatase activity, ankyrin, actin 
cytoskelton 
Dynein Cytoplasmic 1 
Light Intermediate 
Chain 2 
DYNC1
LI2 1.25 microtubule cytoskeleton, microtubule motor activity 
Dynein Cytoplasmic 1 
Heavy Chain 1 
DYNC1
H1 1.23 
microtubule cytoskeleton organization, cell cycle, 
microtubule motor activity 
Tropomyosin 4 TPM4 1.22 actin cytoskeleton 
 
 
